Results 151 to 160 of about 1,221,411 (264)

2024 Update of the Asia‐Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management

open access: yesInternational Journal of Rheumatic Diseases, Volume 29, Issue 7, July 2026.
ABSTRACT Aim To update the Asia‐Pacific League of Associations for Rheumatology (APLAR) treatment recommendations for rheumatoid arthritis (RA) by incorporating new evidence and reassessing the validity of previous guidance: Methods A literature search for relevant publications from January 2018 to August 2023 was conducted, supplemented by earlier ...
Kunihiro Yamaoka   +22 more
wiley   +1 more source

Prevalence of HBV DNA in anti-HBe+ chronic HBV carriers in Babol, 2002

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2004
Background and Objective: One of the most important mutations, which occur in hepatitis B virus, is precore mutant. This mutation is associated with highly productive infection in anti-HBe+ chronic HBV carriers. These chronic HBV carriers are predisposed
MR Hassanjani Roshan   +2 more
doaj  

Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis D

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 2, Page 196-207, July 2026.
Bulevirtide increases bile acid levels in most patients; however, changes in bile acids do not predict virological response or adverse events, nor do they reflect treatment adherence. After discontinuation of bulevirtide, bile acid levels rapidly decline.
Marlene Hintersteininger   +14 more
wiley   +1 more source

Relation of Hbv-DNA levels between serum alanin aminotransferases and serologıc markers of HBV

open access: yes, 2006
Amaç: Serum HBV-DNA miktarları ile yaş, cinsiyet, serum alanin aminotransferaz (ALT) düzeyleri arasındaki ilişki varlığını incelemek. Gereç ve Yöntem: Bu çalışmada serum HBV-DNA miktarları bilinen 90 hastanın yaş, cinsiyet, serum alanin aminotransferaz ...
Zeynep Sümer   +3 more
core  

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity

open access: yesImmunological Reviews, Volume 340, Issue 1, July 2026.
ABSTRACT Advances in high‐throughput sequencing, single‐cell profiling, and genome engineering have transformed the study of T cell receptors (TCRs), enabling the identification and functional interrogation of antigen‐specific repertoires at an unprecedented scale.
Kilian Schober
wiley   +1 more source

Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line.

open access: yes, 1985
Using molecular hybridization we studied the presence and state of HBV DNA in sperm samples obtained from 17 patients with HBV infection (eight HBsAg chronic carrier, nine acute hepatitis B).
Degos F   +6 more
core  

Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 7, July 2026.
ABSTRACT The epidemiological landscape of paired hepatitis B virus (HBV)/hepatitis delta virus (HDV) genotype (GT) among patients with HDV in the US remains unknown. HBV/HDV genotypes were assessed in two independent US cohorts: Cohort 1 included 5222 HBV‐positive patients from Quest Diagnostics, including 114 anti‐HDV+ patients; Cohort 2 included 178 ...
Andrew Lopez   +17 more
wiley   +1 more source

HERACLIS_BLV_D: Adherence to Real‐Life Therapy With Bulevirtide in Chronic Hepatitis D

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 7, July 2026.
ABSTRACT Daily subcutaneous bulevirtide (BLV) 2 mg has been approved as first‐line treatment for chronic hepatitis D (CHD), but long‐term real‐world adherence data are limited. We assessed adherence rates during BLV therapy and their impact on treatment response. HERACLIS_BLV_D study (NCT05928000) included adult CHD patients initiating BLV 2 mg/day and
Dimitra Lakiotaki   +38 more
wiley   +1 more source

Home - About - Disclaimer - Privacy